2026 ICD-10-CM Diagnosis Code Q85.01Neurofibromatosis, type 1
ICD-10-CM Codes›Q00-Q99›Q80-Q89›Q85
- Billable — Valid for Submission
- POA Exempt
- Chronic Condition
Q85.01 is a billable ICD-10-CM diagnosis code for neurofibromatosis, type 1. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Nervous system congenital anomalies.
Code Identity
Code Classification
Present on Admission (POA)Billing
Q85.01 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- 17q11 deletion syndrome
- Axillary freckling due to neurofibromatosis
- Café au lait spots
- Deletion of part of chromosome 17
- Deletion of part of long arm of chromosome 17
- Elephantiasis neurofibromatosa
- Legius syndrome
- Mosaic neurofibromatosis type 1
- Multiple café-au-lait macules due to neurofibromatosis
- Multiple neurofibromas in neurofibromatosis
- Neurofibromatosis Noonan syndrome
- Neurofibromatosis type 1
- Segmental neurofibromatosis
- Segmental neurofibromatosis type 1
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Von Recklinghausen disease
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Recklinghausen disease - Q85.01
- disease (neurofibromatosis) - Q85.01
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Neurofibromatosis(multiple) (nonmalignant)
- type 1 (von Recklinghausen)
- Recklinghausen disease
- Von Recklinghausen
- disease (neurofibromatosis)
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Neurofibromatosis
Neurofibromatosis is a genetic disorder of the nervous system. It mainly affects how nerve cells form and grow. It causes tumors to grow on nerves. You can get neurofibromatosis from your parents, or it can happen because of a mutation (change) in your genes. Once you have it, you can pass it along to your children.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert Q85.01 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Q85.01Overview
Is Q85.01 (Neurofibromatosis (nonmalignant)) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report neurofibromatosis, type 1 on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is Q85.01 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for neurofibromatosis, type 1 on inpatient claims.
What is the ICD-9 equivalent of Q85.01?
Under the General Equivalence Mappings, neurofibromatosis, type 1 converts to ICD-9-CM 237.71 (neurofibromatosis type I). The mapping is a direct match.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
